| pubmed-article:18276604 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18276604 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18276604 | lifeskim:mentions | umls-concept:C0032659 | lld:lifeskim |
| pubmed-article:18276604 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:18276604 | lifeskim:mentions | umls-concept:C0746883 | lld:lifeskim |
| pubmed-article:18276604 | lifeskim:mentions | umls-concept:C0376249 | lld:lifeskim |
| pubmed-article:18276604 | lifeskim:mentions | umls-concept:C0246584 | lld:lifeskim |
| pubmed-article:18276604 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
| pubmed-article:18276604 | lifeskim:mentions | umls-concept:C1709518 | lld:lifeskim |
| pubmed-article:18276604 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:18276604 | lifeskim:mentions | umls-concept:C1705938 | lld:lifeskim |
| pubmed-article:18276604 | lifeskim:mentions | umls-concept:C1527178 | lld:lifeskim |
| pubmed-article:18276604 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:18276604 | pubmed:dateCreated | 2008-3-19 | lld:pubmed |
| pubmed-article:18276604 | pubmed:abstractText | To establish a cefozopran (a fourth-generation cephem) population pharmacokinetic model using patient data and use it to explore alternative dosage regimens that could optimize the currently used dosing regimen to achieve higher likelihood of pharmacodynamic exposure against pathogenic bacteria. | lld:pubmed |
| pubmed-article:18276604 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18276604 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18276604 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18276604 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18276604 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18276604 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18276604 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18276604 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:18276604 | pubmed:issn | 1460-2091 | lld:pubmed |
| pubmed-article:18276604 | pubmed:author | pubmed-author:NomuraKenichi... | lld:pubmed |
| pubmed-article:18276604 | pubmed:author | pubmed-author:TaniwakiMasaf... | lld:pubmed |
| pubmed-article:18276604 | pubmed:author | pubmed-author:ShimazakiChih... | lld:pubmed |
| pubmed-article:18276604 | pubmed:author | pubmed-author:FujitaNaohisa... | lld:pubmed |
| pubmed-article:18276604 | pubmed:author | pubmed-author:ShimuraKazuho... | lld:pubmed |
| pubmed-article:18276604 | pubmed:author | pubmed-author:MorikawaNorif... | lld:pubmed |
| pubmed-article:18276604 | pubmed:author | pubmed-author:KomoriToshiak... | lld:pubmed |
| pubmed-article:18276604 | pubmed:author | pubmed-author:ShimizuDaisuk... | lld:pubmed |
| pubmed-article:18276604 | pubmed:author | pubmed-author:TaniguchiKyok... | lld:pubmed |
| pubmed-article:18276604 | pubmed:author | pubmed-author:MatsumotoYosu... | lld:pubmed |
| pubmed-article:18276604 | pubmed:author | pubmed-author:IkedaKayoK | lld:pubmed |
| pubmed-article:18276604 | pubmed:author | pubmed-author:IkawaKazuroK | lld:pubmed |
| pubmed-article:18276604 | pubmed:author | pubmed-author:KanbayashiYuk... | lld:pubmed |
| pubmed-article:18276604 | pubmed:author | pubmed-author:FujimotoYoshi... | lld:pubmed |
| pubmed-article:18276604 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18276604 | pubmed:volume | 61 | lld:pubmed |
| pubmed-article:18276604 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18276604 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18276604 | pubmed:pagination | 892-900 | lld:pubmed |
| pubmed-article:18276604 | pubmed:meshHeading | pubmed-meshheading:18276604... | lld:pubmed |
| pubmed-article:18276604 | pubmed:meshHeading | pubmed-meshheading:18276604... | lld:pubmed |
| pubmed-article:18276604 | pubmed:meshHeading | pubmed-meshheading:18276604... | lld:pubmed |
| pubmed-article:18276604 | pubmed:meshHeading | pubmed-meshheading:18276604... | lld:pubmed |
| pubmed-article:18276604 | pubmed:meshHeading | pubmed-meshheading:18276604... | lld:pubmed |
| pubmed-article:18276604 | pubmed:meshHeading | pubmed-meshheading:18276604... | lld:pubmed |
| pubmed-article:18276604 | pubmed:meshHeading | pubmed-meshheading:18276604... | lld:pubmed |
| pubmed-article:18276604 | pubmed:meshHeading | pubmed-meshheading:18276604... | lld:pubmed |
| pubmed-article:18276604 | pubmed:meshHeading | pubmed-meshheading:18276604... | lld:pubmed |
| pubmed-article:18276604 | pubmed:meshHeading | pubmed-meshheading:18276604... | lld:pubmed |
| pubmed-article:18276604 | pubmed:meshHeading | pubmed-meshheading:18276604... | lld:pubmed |
| pubmed-article:18276604 | pubmed:meshHeading | pubmed-meshheading:18276604... | lld:pubmed |
| pubmed-article:18276604 | pubmed:meshHeading | pubmed-meshheading:18276604... | lld:pubmed |
| pubmed-article:18276604 | pubmed:meshHeading | pubmed-meshheading:18276604... | lld:pubmed |
| pubmed-article:18276604 | pubmed:meshHeading | pubmed-meshheading:18276604... | lld:pubmed |
| pubmed-article:18276604 | pubmed:meshHeading | pubmed-meshheading:18276604... | lld:pubmed |
| pubmed-article:18276604 | pubmed:meshHeading | pubmed-meshheading:18276604... | lld:pubmed |
| pubmed-article:18276604 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18276604 | pubmed:articleTitle | Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis. | lld:pubmed |
| pubmed-article:18276604 | pubmed:affiliation | Department of Haematology and Oncology, Kyoto Prefectural University of Medicine Graduate School of Medical Sciences, Kyoto, Japan. nomuken@koto.kpu-m.ac.jp | lld:pubmed |
| pubmed-article:18276604 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18276604 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:18276604 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
